Seer to Participate in the Morgan Stanley Global Healthcare Conference
August 30 2022 - 4:05PM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that the
company will be participating in the upcoming Morgan Stanley Global
Healthcare Conference in New York City, New York.
Seer’s management is scheduled to participate in
a fireside chat on Tuesday, September 13th at 8:35 a.m. Eastern
Time / 5:35 a.m. Pacific Time. A live webcast of the session will
be available on the Investor section of Seer’s website at
investor.seer.bio. An archived replay will be available on the
company’s website following the conference.
About Seer Seer™ is a life
sciences company developing transformative products that open a new
gateway to the proteome. Seer’s Proteograph™ Product Suite is an
integrated solution that includes proprietary engineered
nanoparticles, consumables, automation instrumentation and software
to perform deep, unbiased proteomic analysis at scale in a matter
of hours. Seer designed the Proteograph workflow to be efficient
and easy to use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
incorporated by nearly any lab. Seer’s Proteograph Product Suite is
for research use only and is not intended for diagnostic
procedures. For more information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren
Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024